Roche acquires Genia Technologies to strengthen next generation sequencing pipeline
2 June 2014 | By Roche
Roche announced the acquisition of Genia Technologies, Inc., a privately held company, based in Mountain View, California, USA...
List view / Grid view
News
GSK announces Phase III ALTTO results for anti-HER2 therapy combination in the adjuvant breast cancer treatment setting
2 June 2014 | By GlaxoSmithKline
GlaxoSmithKline plc announced that the Phase III study of two anti-HER2 agents, lapatinib (Tykerb™/Tyverb™) and trastuzumab, did not meet the primary endpoint of improved disease free survival...
Leading experts from pharma and biotech companies to meet in London in September at Biosimilars and Biobetters Conference
29 May 2014 | By SMI Group
Impending patent expirations on blockbuster biologics and a volatile financial environment is causing payers to seek wider adoption of biosimilars in order to manage growing healthcare costs...
Bionetworks: reviewing the various collaborations between pharma, biotech, academia and venture capitalists
29 May 2014 | By SMI Group
Companies are realizing that their own internal R&D groups alone are not enough and as pharma groups slash their internal R&D projects...
George Weinstock to Keynote at Next Generation Seq Meeting on June 19-20, 2014 in San Diego, CA
29 May 2014 | By GTCBio
George Weinstock, Professor and Associate Director at The Jackson Laboratory for Genomic Medicine to give a keynote presentation on “Exploring the Role of the Microbiome in Disease”...
John Herrmann, CSO, Eli Lilly to Keynote at Novel Cancer Therapeutics Summit – July 7-8, 2014 Boston
29 May 2014 | By GTCBio
John Herrmann, Chief Science Officer of Global External Research & Development, Oncology at Eli Lilly To Give a Keynote Presentation on “Partnering with Lilly Oncology: Current Priorities, NYC Innovation Hub Model & Possible Future States” at the Novel Cancer Therapeutics Summit 2014...
Dainippon Sumitomo Pharma and Daiichi Sankyo cooperate on lurasidone, an atypical antipsychotic agent, in four South American countries
27 May 2014 | By Daiichi Sankyo
Dainippon Sumitomo Pharma Co., Ltd. and Daiichi Sankyo Co., Ltd. announced that they have entered into a license agreement for the commercialization of lurasidone hydrochloride...
Pfizer announces detailed results for Phase 3 OPT retreatment study of tofacitinib in adults with moderate-to-severe chronic plaque psoriasis
23 May 2014 | By Pfizer
Pfizer Inc. announced detailed results from the Oral treatment Psoriasis Trial Retreatment study, a Phase 3 study investigating tofacitinib for the treatment of adult patients with moderate-to-severe chronic plaque psoriasis...
Sanford-Burnham and Daiichi Sankyo form alliance to study novel drug targets in cardiovascular-metabolic diseases
22 May 2014 | By Daiichi Sankyo
Sanford-Burnham Medical Research Institute and Daiichi Sankyo Co., Ltd. announced they have entered into a three-year comprehensive alliance to develop first-in-class therapeutics for the treatment of cardiovascular-metabolic diseases...
PerkinElmer launches next generation high content screening system
19 May 2014 | By PerkinElmer
The Opera Phenix™ delivers uncompromising speed and sensitivity, accelerating the understanding of disease and discovery of new and more effective treatment therapies...
Eureka Conferences Inc. announces Drug Discovery & Therapy World Congress 2014
19 May 2014 | By Eureka Conferences
Eureka Conferences is pleased to announce Drug Discovery & Therapy World Congress 2014, scheduled to be held from 16th - 19th June, 2014...
IPF Phase III results published in NEJM show nintedanib* slows disease progression
19 May 2014 | By Boehringer Ingelheim
Results from the Phase III INPULSIS™ trials, published online in the New England Journal of Medicine, show nintedanib* significantly slowed disease progression in patients with idiopathic pulmonary fibrosis...
Pharma R&D Europe summits series – registration closing
16 May 2014 | By Oxford Global Conferences
Registration is now closing for Oxford Global’s Pharma R&D Europe Series, the leading pharmaceutical discussion forum in Europe...
American College of Physicians, CECity, and Pfizer collaborate to increase adult immunization rates
16 May 2014 | By Pfizer
The American College of Physicians announced a new initiative designed to increase adult immunization rates by assisting physicians and other health care providers in strongly recommending appropriate vaccination...
Abbott expands Latin American presence and branded generics portfolio with acquisition of CFR Pharmaceuticals
16 May 2014 | By Abbott
Abbott enhances its position in fast-growing Latin American market, more than doubling its branded generics pharmaceutical sales and presence in the region...